Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
26 Jul 2016 Press Release: ESMO Publishes Results of European Consortium Study on the Availability of Anti-neoplastic Medicines
25 Jul 2016 EMA Recommends Extension of Therapeutic Indications for Crizotinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jul 2016 EMA Recommends Granting a Marketing Authorisation for Cabozantinib in Advanced RCC Genitourinary cancers - Anticancer agents & Biologic therapy
21 Jul 2016 Press Release: ESMO 2018 Annual Congress to be Held in Munich
20 Jul 2016 PRAC Concludes Review of Idelalisib and Issues Updated Recommendations for Use Haematologic malignancies - Anticancer agents & Biologic therapy
18 Jul 2016 Acquired Resistance to PD-1 Blockade in Melanoma Translational research - Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
14 Jul 2016 FDA Approves First HPV Test for Use with SurePath Preservative Fluid Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies
14 Jul 2016 World GI 2016 Press Release: The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress on Gastrointestinal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
13 Jul 2016 Statistical Perspective on Adaptive Strategy for Matching Targeted Therapies with the Patients Most Likely to Benefit Breast cancer - Anticancer agents & Biologic therapy
12 Jul 2016 Biomarker Tests for Molecularly Targeted Therapies Personalised medicine - Bioethics, legal and economic issues
11 Jul 2016 FDA Advances Precision Medicine Initiative by Issuing Two Draft Guidances on NGS-Based Tests Personalised medicine - Bioethics, legal and economic issues
07 Jul 2016 Press Release: Results of First Study Assessing Clinical Impact of ESMO-MCBS
07 Jul 2016 NICE Issues Quality Standard on Suspected Cancer Epidemiology/Etiology/Cancer Prevention - Imaging
06 Jul 2016 Press Release: ESMO Releases New Consensus Guidelines on the Management of Metastatic Colorectal Cancer Gastrointestinal cancers
06 Jul 2016 EMA Recommends to Refuse a Change to the Marketing Authorisation for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy